EUVIMEDEUVIMED entdecken
Open Access

Ultrathin-strut versus thin-strut stent healing and outcomes in preclinical and clinical subjects

Ryutaro Ikegami, Zhonglie Piao, Juan F Iglesias, Thomas Pilgrim, Khanh Ha, Jason R McCarthy, Maria I Castellanos, Mohamad B Kassab, Mazen S Albagdadi, Adam Mauskapf, Graham Spicer, David E Kandzari und 6 weitere

EuroIntervention · 2024

DOI: 10.4244/eij-d-23-00563 ↗

Kurz gefasst

Fachartikel in der Zeitschrift EuroIntervention, 2024. Verfasst von Ryutaro Ikegami und 17 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Cardiovascular Research Center, Massachusetts General Hospital, Boston, MA, USA. Hauptthemen laut MEDLINE: Drug-Eluting Stents, Percutaneous Coronary Intervention, Sirolimus, Tomography, Optical Coherence. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Compared with thin-strut durable-polymer drug-eluting stents (DP-DES), ultrathin-strut biodegradable-polymer sirolimus-eluting stents (BP-SES) improve stent-related clinical outcomes in patients undergoing percutaneous coronary intervention (PCI). Reduced stent strut thickness is hypothesised to underlie these benefits, but this conjecture remains unproven. AIMS: We aimed to assess the impact of strut thickness on stent healing and clinical outcomes between ultrathin-strut and thin-strut BP-SES. METHODS: First, we performed a preclinical study of 8 rabbits implanted with non-overlapping thin-strut (diameter/thickness 3.5 mm/80 μm) and ultrathin-strut (diameter/thickness 3.0 mm/60 μm) BP-SES in the infrarenal aorta. On day 7, the rabbits underwent intravascular near-infrared fluorescence optical coherence tomography (NIRF-OCT) molecular-structural imaging of fibrin deposition and stent tissue coverage, followed by histopathological analysis. Second, we conducted an individual data pooled analysis of patients enrolled in the BIOSCIENCE and BIOSTEMI randomised PCI trials treated with ultrathin-strut (n=282) or thin-strut (n=222) BP-SES. The primary endpoint was target lesion failure (TLF) at 1-year follow-up, with a landmark analysis at 30 days. RESULTS: NIRF-OCT image analyses revealed that ultrathin-strut and thin-strut BP-SES exhibited similar stent fibrin deposition (p=0.49) and percentage of uncovered stent struts (p=0.63). Histopathological assessments corroÂborated these findings. In 504 pooled randomised trial patients, TLF rates were similar for those treated with ultrathin-strut or thin-strut BP-SES at 30-day (2.5% vs 1.8%; p=0.62) and 1-year follow-up (4.3% vs 4.7%; p=0.88). CONCLUSIONS: Ultrathin-strut and thin-strut BP-SES demonstrate similar early arterial healing profiles and 30-day and 1-year clinical outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug-Eluting StentsPercutaneous Coronary InterventionSirolimusTomography, Optical CoherenceAnimalsRabbitsHumansTreatment OutcomeProsthesis DesignCoronary Artery DiseaseMaleAbsorbable ImplantsFemaleWound Healing

Substanzen

Sirolimus

Autor:innen und Institutionen

  • Division of Cardiology, Cardiovascular Research Center, Massachusetts General Hospital, Boston, MA, USA.
  • Department of Cardiovascular Biology and Medicine, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
  • Wellman Center for Photomedicine, Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA.
  • Department of Cardiology, Geneva University Hospitals, Geneva, Switzerland.
  • Bern University Hospital, Bern, Switzerland.
  • Masonic Medical Research Institute, Utica, NY, USA.

Förderung

  • NHLBI NIH HHS

Zitieren

APA

Ikegami, R., Piao, Z., Iglesias, J. F., Pilgrim, T., Ha, K., McCarthy, J. R., Castellanos, M. I., Kassab, M. B., Albagdadi, M. S., Mauskapf, A., Spicer, G., Kandzari, D. E., Edelman, E. R., Libby, P., Heg, D., Joner, M., Tearney, G. J., & Jaffer, F. A. (2024). Ultrathin-strut versus thin-strut stent healing and outcomes in preclinical and clinical subjects. EuroIntervention. https://doi.org/10.4244/eij-d-23-00563

Vancouver

Ikegami R, Piao Z, Iglesias JF, Pilgrim T, Ha K, McCarthy JR, et al. Ultrathin-strut versus thin-strut stent healing and outcomes in preclinical and clinical subjects. EuroIntervention. 2024. doi:10.4244/eij-d-23-00563

BibTeX
@article{Ikegami2024,
  author = {Ikegami, Ryutaro and Piao, Zhonglie and Iglesias, Juan F and Pilgrim, Thomas and Ha, Khanh and McCarthy, Jason R and Castellanos, Maria I and Kassab, Mohamad B and Albagdadi, Mazen S and Mauskapf, Adam and Spicer, Graham and Kandzari, David E and Edelman, Elazer R and Libby, Peter and Heg, Dik and Joner, Michael and Tearney, Guillermo J and Jaffer, Farouc A},
  title = {Ultrathin-strut versus thin-strut stent healing and outcomes in preclinical and clinical subjects},
  journal = {EuroIntervention},
  year = {2024},
  doi = {10.4244/eij-d-23-00563}
}
Kostenlos starten →